Journal article

Whole-genome landscapes of major melanoma subtypes

Nicholas K Hayward, James S Wilmott, Nicola Waddell, Peter A Johansson, Matthew A Field, Katia Nones, Ann-Marie Patch, Hojabr Kakavand, Ludmil B Alexandrov, Hazel Burke, Valerie Jakrot, Stephen Kazakoff, Oliver Holmes, Conrad Leonard, Radhakrishnan Sabarinathan, Loris Mularoni, Scott Wood, Qinying Xu, Nick Waddell, Varsha Tembe Show all

Nature | NATURE PUBLISHING GROUP | Published : 2017

Grants

Awarded by European Research Council


Awarded by Los Alamos National Laboratory Institutional Computing Program


Funding Acknowledgements

This work was supported by Melanoma Institute Australia, Bioplatforms Australia, the New South Wales Ministry of Health, Cancer Council NSW, National Health and Medical Research Council of Australia (NHMRC), Cancer Institute NSW, Australian Cancer Research Foundation and the National Collaborative Research Infrastructure Strategy. N.K.H., Nicola W., R.A.S., J.S.W. and K.D.-R. were supported by NHMRC Fellowships, K.N. by a Keith Boden Fellowship, G.V.L. by the University of Sydney Medical Foundation, M.S. by Pfizer Australia, the Victorian Endowment for Knowledge, Science and Innovation and NHMRC, L.B.A. by a J. Robert Oppenheimer Fellowship at Los Alamos National Laboratory, and N.L.-B. by the European Research Council (Consolidator Grant 682398). Biobanking was supported by Melanoma Institute Australia, the Victorian Cancer Agency, Victorian Cancer Biobank, Victorian State Government Operational Infrastructure Support Program, Melanoma Research Alliance and the Melbourne Melanoma Project, and the efforts of patients, clinicians and other staff at health services across Australia. Cell lines were provided via the ABN-Oncology group, supported by NHMRC. Research at Los Alamos National Laboratory was under the auspices of the National Nuclear Security Administration of the US Department of Energy; the Los Alamos National Laboratory Institutional Computing Program was supported by contract DE-AC52-06NA25396. We acknowledge the support of colleagues at Melanoma Institute Australia, Royal Prince Alfred Hospital, NSW Health Pathology, Westmead Institute for Medical Research, Peter MacCallum Cancer Centre and Olivia Newton-John Cancer Research Institute. We thank D. Stetner for computing assistance.